Walter S D
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Stat Med. 2002 May 15;21(9):1237-56. doi: 10.1002/sim.1099.
The summary receiver operating characteristic (SROC) curve has been recommended to represent the performance of a diagnostic test, based on data from a meta-analysis. However, little is known about the basic properties of the SROC curve or its estimate. In this paper, the position of the SROC curve is characterized in terms of the overall diagnostic odds ratio and the magnitude of inter-study heterogeneity in the odds ratio. The area under the curve (AUC) and an index Q() are discussed as potentially useful summaries of the curve. It is shown that AUC is maximized when the study odds ratios are homogeneous, and that it is quite robust to heterogeneity. An upper bound is derived for AUC based on an exact analytic expression for the homogeneous situation, and a lower bound based on the limit case Q(), defined by the point where sensitivity equals specificity: Q() is invariant to heterogeneity. The standard error of AUC is derived for homogeneous studies, and shown to be a reasonable approximation with heterogeneous studies. The expressions for AUC and its standard error are easily computed in the homogeneous case, and avoid the need for numerical integration in the more general case. SE(AUC) and SE(Q()) are found to be numerically close, with SE(Q(*)) being larger if the odds ratio is very large. The methods are illustrated using data for the Pap smear screening test for cervical cancer, and for three tests for the diagnosis of metastases in cervical cancer patients.
基于荟萃分析的数据,推荐使用汇总受试者工作特征(SROC)曲线来表示诊断试验的性能。然而,对于SROC曲线及其估计值的基本特性知之甚少。在本文中,SROC曲线的位置通过总体诊断比值比和比值比研究间异质性的大小来表征。讨论了曲线下面积(AUC)和指数Q()作为曲线潜在有用的汇总指标。结果表明,当研究比值比相同时,AUC最大,并且它对异质性具有很强的稳健性。基于同质情况的精确解析表达式推导出AUC的上限,基于敏感性等于特异性的点所定义的极限情况Q()推导出下限:Q()对异质性不变。推导了同质研究中AUC的标准误差,并表明在异质研究中它是一个合理的近似值。在同质情况下,AUC及其标准误差的表达式易于计算,并且在更一般的情况下无需进行数值积分。发现SE(AUC)和SE(Q())在数值上接近,如果比值比非常大,则SE(Q(*))更大。使用宫颈癌巴氏涂片筛查试验的数据以及宫颈癌患者转移诊断的三项试验对这些方法进行了说明。